Concepedia

N. Andrew Whitlock

NA

6

Publications

437

Citations

6

H-Index

2005

Active since

Affiliations

Lexicon Pharmaceuticals (United States)(Current)

Medical University of South Carolina

University of North Texas Health Science Center

University of North Texas

N. Andrew Whitlock is an author at Lexicon Pharmaceuticals (United States) specializing in glaucoma, ocular pharmacology, and ophthalmology.

Top concepts

Publications per year

2005–2014

6

Publications

6

Hsp27 Upregulation by HIF-1 Signaling Offers Protection against Retinal Ischemia in Rats

N. Andrew Whitlock, Neeraj Agarwal, Jian‐xing Ma et al. · Investigative Ophthalmology & Visual Science · 2005 · 120 citations

Increased Intraocular Pressure in Mice Treated with Dexamethasone

N. Andrew Whitlock, Beth McKnight, Katie N. Corcoran et al. · Investigative Ophthalmology & Visual Science · 2010 · 87 citations

Novel Class of LIM-Kinase 2 Inhibitors for the Treatment of Ocular Hypertension and Associated Glaucoma

Bryce A. Harrison, N. Andrew Whitlock, Michael Voronkov et al. · Journal of Medicinal Chemistry · 2009 · 77 citations · Full text

, , +14

Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma

Bryce A. Harrison, Zheng Y. Almstead, Hugh A. Burgoon et al. · ACS Medicinal Chemistry Letters · 2014 · 60 citations · Full text

, , +14

Heat Shock Protein 27 Delays Ca<sup>2+</sup>-Induced Cell Death in a Caspase-Dependent and -Independent Manner in Rat Retinal Ganglion Cells

N. Andrew Whitlock, K.M. Lindsey, Neeraj Agarwal et al. · Investigative Ophthalmology & Visual Science · 2005 · 54 citations · Full text

Rows per page

1–5 of 6